https://www.biospace.com/ironwood-announces-publication-in-the-lancet-gastroenterology-and-amp-hepatology-of-new-linaclotide-phase-iii-data-in-children-and-adolescents-aged-6-17-years-with-functional-constipation
Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase...
Jul 17, 2024 - Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that new data from the Phase III study that evaluated...
in the